Feifeng Song

996 total citations
53 papers, 717 citations indexed

About

Feifeng Song is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feifeng Song has authored 53 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feifeng Song's work include Drug Transport and Resistance Mechanisms (11 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (4 papers). Feifeng Song is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (4 papers). Feifeng Song collaborates with scholars based in China, United States and Ethiopia. Feifeng Song's co-authors include Huidi Jiang, David E. Smith, Yongjun Hu, Zhongjian Chen, Liping Li, Ping Huang, Zongfu Pan, Xiuli Yang, Gabriel Núñez and Xiao Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and British Journal of Pharmacology.

In The Last Decade

Feifeng Song

49 papers receiving 707 citations

Peers

Feifeng Song
Magdalena Milczarek Poland
Miguel Muzzio United States
Sharavan Ramachandran United States
Guoguo Jin China
Sonam Mittal India
Anna Wawruszak Poland
Qunyi Li China
Lingtao Jin United States
Benson Chellakkan Selvanesan India
Magdalena Milczarek Poland
Feifeng Song
Citations per year, relative to Feifeng Song Feifeng Song (= 1×) peers Magdalena Milczarek

Countries citing papers authored by Feifeng Song

Since Specialization
Citations

This map shows the geographic impact of Feifeng Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifeng Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifeng Song more than expected).

Fields of papers citing papers by Feifeng Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifeng Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifeng Song. The network helps show where Feifeng Song may publish in the future.

Co-authorship network of co-authors of Feifeng Song

This figure shows the co-authorship network connecting the top 25 collaborators of Feifeng Song. A scholar is included among the top collaborators of Feifeng Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifeng Song. Feifeng Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Han, Bing, Mengyu Chen, Di Mu, et al.. (2025). USP14 and UCHL5 synergistically deubiquitinate PKCα and translocate NF-κB to promote the progression of anaplastic thyroid cancer. Cell Death and Disease. 16(1). 617–617.
3.
Song, Feifeng, et al.. (2025). Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy. Drug Resistance Updates. 83. 101286–101286. 1 indexed citations
4.
Zhang, Wanli, Yiwen Zhang, Zhentao Zhang, et al.. (2025). Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies. European journal of medical research. 30(1). 69–69. 7 indexed citations
5.
Xu, Tong, et al.. (2024). Ophiopogonin D′ inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling. Journal of Cellular and Molecular Medicine. 28(16). e70014–e70014. 1 indexed citations
6.
Ren, Yan, et al.. (2024). Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D. Pharmaceutics. 16(12). 1600–1600. 2 indexed citations
7.
Song, Feifeng, Zhentao Zhang, Tong Xu, et al.. (2024). Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis. Advanced Science. 11(24). e2306671–e2306671. 4 indexed citations
8.
Zhang, Yiwen, Lu Lu, Feifeng Song, et al.. (2023). Research progress on non-protein-targeted drugs for cancer therapy. Journal of Experimental & Clinical Cancer Research. 42(1). 62–62. 14 indexed citations
9.
Zhang, Qi, et al.. (2023). A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment. Cancer Cell International. 23(1). 16–16. 17 indexed citations
10.
Xu, Tong, Jinming Chen, Feifeng Song, et al.. (2023). ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 182–182. 13 indexed citations
11.
12.
Song, Feifeng, Mengting Cheng, Ying Hu, et al.. (2023). Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats. PeerJ. 11. e15844–e15844. 34 indexed citations
13.
Song, Feifeng, Qi Zhang, Tong Xu, et al.. (2023). Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma. Journal of Physiology and Biochemistry. 79(4). 757–770. 4 indexed citations
14.
Pan, Zongfu, Xiao Hu, Tiefeng Jin, et al.. (2022). CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Molecular Cancer. 21(1). 190–190. 68 indexed citations
15.
Zhang, Yiwen, Yujia Liu, Xiao Hu, et al.. (2021). Stemness-associated senescence genes as potential novel risk factors for papillary renal cell carcinoma. Translational Andrology and Urology. 10(11). 4241–4252. 4 indexed citations
16.
Cheng, Xiang, Yu Zhang, Feifeng Song, et al.. (2020). URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Ye, Xiaolan, Zhe Wang, Qiang Ye, et al.. (2020). High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis. Frontiers in Immunology. 11. 1618–1618. 26 indexed citations
18.
Ye, Xiaolan, Jian Wu, Yan Ren, et al.. (2020). Case report: severe myoclonus associated with oral midodrine treatment for hypotension. Medicine. 99(40). e21533–e21533. 2 indexed citations
19.
Wang, Yuqing, Ping Li, Feifeng Song, et al.. (2019). Substrate Transport Properties of the Human Peptide/Histidine Transporter PHT2 in Transfected MDCK Cells. Journal of Pharmaceutical Sciences. 108(10). 3416–3424. 7 indexed citations
20.
Song, Feifeng, Yongjun Hu, Huidi Jiang, & David E. Smith. (2016). Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants. Drug Metabolism and Disposition. 45(2). 130–136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Milczarek Breakdown of academic impact, for papers by Miguel Muzzio Breakdown of academic impact, for papers by Sharavan Ramachandran Breakdown of academic impact, for papers by Guoguo Jin Breakdown of academic impact, for papers by Sonam Mittal Breakdown of academic impact, for papers by Anna Wawruszak Breakdown of academic impact, for papers by Qunyi Li Breakdown of academic impact, for papers by Lingtao Jin Breakdown of academic impact, for papers by Benson Chellakkan Selvanesan
Rankless by CCL
2026